December 6, 2021

News

News Network

Statement by Attorney General Merrick B. Garland on Earth Day

8 min read
<div>On April 22, 1970, millions of people across America came together and sparked a movement that led to the enactment of many of our nation’s foundational environmental laws, including the Clean Air Act, the Endangered Species Act, the Clean Water Act, and the Safe Drinking Water Act.</div>
On April 22, 1970, millions of people across America came together and sparked a movement that led to the enactment of many of our nation’s foundational environmental laws, including the Clean Air Act, the Endangered Species Act, the Clean Water Act, and the Safe Drinking Water Act.

More from: April 22, 2021

News Network

  • Department Press Briefing – March 18, 2021
    In Crime Control and Security News
    Jalina Porter, Principal [Read More…]
  • Federal charges filed against operators of Houston stash house
    In Justice News
    Five individuals in the [Read More…]
  • Five Charged in Scheme to Export Thermal Imaging Scopes and Night Vision Goggles to Russia, in Violation of Arms Export Control Act
    In Crime News
    A federal grand jury in Los Angeles unsealed an indictment Thursday that accuses five defendants of conspiring to unlawfully export defense articles to Russia. Specifically, the defendants allegedly exported thermal imaging riflescopes and night-vision goggles without a license, in violation of the Arms Export Control Act.
    [Read More…]
  • Get to Know Preclearance
    In Travel
    Information for [Read More…]
  • Man Sentenced for Operating Multi-Million Dollar International Money Laundering Scheme
    In Crime News
    A Ukrainian man was sentenced today to 87 months in prison and ordered to pay $98,751.64 in restitution after pleading guilty to committing wire fraud, stemming from his participation in a scheme to launder funds for Eastern European cybercriminals who hacked into and stole funds from online bank accounts of U.S. businesses.
    [Read More…]
  • International Women Human Rights Defenders Day
    In Crime Control and Security News
    Ned Price, Department [Read More…]
  • U.S. Government Seizes 68 Protected Big Cats and a Jaguar from Jeffrey and Lauren Lowe
    In Crime News
    The United States has seized 68 protected lions, tigers, lion-tiger hybrids, and a jaguar from Jeffrey and Lauren Lowe’s Tiger King Park in Thackerville, Oklahoma, pursuant to a judicially-authorized search and seizure warrant, for ongoing Endangered Species Act (ESA) violations. The Justice Department will seek civil forfeiture of these animals and any offspring pursuant to the ESA’s forfeiture provision. 
    [Read More…]
  • The United States Applauds the Interim Government’s “People’s Vote”
    In Crime Control and Security News
    Michael R. Pompeo, [Read More…]
  • Former Investment Manager Charged in Scheme to Defraud Life Insurance Company
    In Crime News
    A former investment manager was charged in an indictment unsealed today for his alleged participation in a scheme to defraud a North Carolina-based life insurance company out of over $34 million.
    [Read More…]
  • United States Condemns Violence Against Peaceful Protesters in Sudan
    In Crime Control and Security News
    Ned Price, Department [Read More…]
  • GSA Online Marketplaces: Plans to Measure Progress and Monitor Data Protection Efforts Need Further Development
    In U.S GAO News
    What GAO Found The General Services Administration (GSA) is testing the concept of using online marketplaces where purchase card holders at federal agencies can easily buy commercially available products. In June 2020, GSA awarded contracts to three platform providers in what it calls the commercial platforms program. Through the program, 13 participating federal agencies can purchase products up to the micro-purchase threshold (generally $10,000). The three platforms vary, but all have characteristics that serve the needs of government purchase card holders. See table. Selected Online Platform Characteristics Platform characteristic Amazon Business Fisher Scientific Company L.L.C. Overstock Government Tailored commercial site for government platform No Yes Yes Promotes own products Yes Yes No Ability to restrict sale of prohibited products/suppliersa Yes Yes Yes Ability to designate preferred products/suppliersa Yes Yes Yes Source: GAO analysis of platform providers' information. | GAO-21-104572 aSuspended or debarred contractors are examples of prohibited suppliers. Preferred products or suppliers include environmentally sustainable products or small businesses. GSA has established initial metrics for measuring program implementation, but it has not yet created a comprehensive plan with goals or clear time frames for assessing program progress. For example, GSA stated that it will track how sales are distributed across the three platforms, but it has not identified a goal of what percentage of sales across them is appropriate or the time frame to achieve that goal. As the program progresses, GSA can start to change its focus from testing the commercial platforms program concept to measuring progress. Establishing a comprehensive plan that outlines goals and time frames for each metric will better position GSA to measure if the program is being implemented successfully or if the program needs changes before it is ultimately expanded government-wide, as is the current plan. GSA developed a plan to oversee each platform provider's compliance with requirements to protect government and supplier data. But it did not address some areas of compliance, and some actions within the plan may not effectively prevent unauthorized activity. For example, the data protection requirement prohibits providers from using third-party supplier data for pricing, marketing, or other activities. GSA's monitoring plan states that it will track sales of products supplied by the providers and compare them to products from third-party suppliers. However, this approach does not clearly demonstrate whether a provider violated the data protection requirement. By including specific actions, such as regular reviews of providers' policies in its monitoring plan, GSA will be better positioned to ensure that providers comply with the requirements to protect supplier or government data from unauthorized use. Why GAO Did This Study In fiscal year 2018, Congress directed GSA and the Office of Management and Budget to establish and implement a program for agencies to buy products through online marketplaces to, among other things, enhance competition and expedite the procurement process for certain commercial products. It also directed GSA to include in related contracts certain requirements to protect government and supplier data from unauthorized disclosure and use. A House report accompanying the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 included a provision for GAO to review GSA's ability to monitor providers' compliance with data protection requirements. This report examines GSA's implementation of the commercial platforms program, the extent to which GSA is measuring program progress, and GSA's oversight of platform providers' efforts to protect data from unauthorized disclosure and use. GAO reviewed GSA's program guidance, and the three commercial platform providers' contracts, policies, and practices. GAO also reviewed GSA's plan for measuring metrics and oversight and interviewed GSA officials and platform representatives about data protection and monitoring policies and practices.
    [Read More…]
  • FEDERAL COURT RESTRAINS TAMPA PHARMACY AND TWO INDIVIDUALS FROM DISPENSING OPIOIDS OR OTHER CONTROLLED SUBSTANCES
    In Crime News
    A federal court in Florida issued a temporary restraining order enjoining a Tampa pharmacy and two of its employees from dispensing opioids and other controlled substances, the Department of Justice announced today.
    [Read More…]
  • Drug Development: Pathway for Approving Antibacterial and Antifungal Drugs for Patients with Limited Treatment Options is Infrequently Used
    In U.S GAO News
    What GAO Found Antibacterial and antifungal infections resistant to available drugs are a serious public health challenge. However, the number of drugs under development may be insufficient to meet this threat, in part because developers face economic and other challenges in developing drugs for these conditions, many of which are still relatively rare. The Food and Drug Administration (FDA) may use a certain pathway—known as the limited population pathway for antibacterial and antifungal drugs (LPAD)—to approve drugs intended to treat serious or life-threatening infections that affect a limited group of patients and are not adequately addressed by available therapy. LPAD does not fundamentally change FDA's drug approval process, but it does provide tools that can help the agency accept greater risk and uncertainty when deciding to approve a drug for these otherwise difficult to treat infections, according to FDA officials. As a result, officials say FDA may approve a drug for a limited population because of the potential benefits for these patients, despite risks that would be unacceptable if the drug was intended to treat a broader population. GAO's review of FDA documentation shows that since LPAD was established in 2016, drug developers have formally requested approval under LPAD for four drugs, two of which were approved: Two Drugs Approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD), as of June 2021 Drug Name Condition approved to treat Population with condition Arikayce Treatment of a bacterial infection in the lung called refractory Mycobacterium avium complex lung disease Fewer than 27 per 100,000 persons older than 60 years of age Pretomanid Treatment of types of highly drug-resistant tuberculosis 123 cases reported in the United States in 2017 Source: Food and Drug Administration and Centers for Disease Control and Prevention. | GAO-22-105042 FDA and stakeholders agreed that LPAD's effect on the drug pipeline could be limited because the pathway does not address the economic challenges facing the development of these products. For example, according to stakeholders, given the limited market for such drugs, sales revenue can be insufficient to cover development costs, making it difficult for companies to survive in the antibacterial and antifungal drug market. In March 2020, GAO reported on similar challenges and recommended that the Department of Health and Human Services (HHS) develop a strategy to further incentivize the development of new treatments for antibiotic-resistant infections, including the use of post-market financial incentives, which could include rewards for market entry or reimbursement reform. HHS did not concur with this recommendation, and as of June 2021, the agency indicated that it was still examining the issue and this recommendation had not been implemented. Why GAO Did This Study It is estimated that at least 2.8 million antibacterial and antifungal-resistant infections occur each year in the United States, and more than 35,000 people die as a result, according to the Centers for Disease Control and Prevention. The development of new antibacterial and antifungal treatments is one strategy to address the threat of antimicrobial resistance. The 21st Century Cures Act, enacted in 2016, established LPAD to help facilitate the approval of certain antibacterial and antifungal drugs. FDA oversees the approval of such drugs. The 21st Century Cures Act includes a provision for GAO to review and report on FDA's LPAD activities. This report describes (1) the extent to which LPAD changes FDA's drug approval process, (2) the extent to which drug developers have sought to use LPAD for drugs under development, and (3) stakeholders' and FDA's views on the effectiveness of LPAD in benefiting the development and approval of antibacterial and antifungal drugs. GAO reviewed FDA guidance documents; documentation from the approval process; and drug developers' written statements to investors and FDA on LPAD. GAO also interviewed FDA officials and obtained information from 10 stakeholders selected because they sought approval for a drug through LPAD, considered using LPAD, or provided written comment to FDA on LPAD. These included two industry associations, one think tank, and seven drug developers. HHS provided technical comments on a draft of this report, which GAO incorporated as appropriate. For more information, contact Mary Denigan-Macauley at (202) 512-7114 or deniganmacauleym@gao.gov.
    [Read More…]
  • Over 500K Rapid Coronavirus Tests Being Distributed to HBCUs
    In Human Health, Resources and Services
    In yet another effort by [Read More…]
  • U.S.-ASEAN Smart Cities Partnership (USASCP): Sharing Expertise Between Cities to Benefit the People of ASEAN
    In Crime Control and Security News
    Office of the [Read More…]
  • Secretary Blinken’s Meeting with Ukrainian President Zelenskyy
    In Climate - Environment - Conservation
    Office of the [Read More…]
  • Amec Foster Wheeler Energy Limited Agrees to Pay Over $18 Million to Resolve Charges Related to Bribery Scheme in Brazil
    In Crime News
    Amec Foster Wheeler Energy Limited (Amec Foster Wheeler or the Company), a subsidiary of John Wood Group plc (Wood), a United Kingdom-based global engineering company, has agreed to pay $18,375,000 to resolve criminal charges stemming from a scheme to pay bribes to officials in Brazil in exchange for an approximately $190 million contract to design a gas-to-chemicals complex.
    [Read More…]
  •  Secretary Blinken’s Call with Czech Prime Minister Babiš
    In Crime Control and Security News
    Office of the [Read More…]
  • Local man sentenced after shop owner shot in violent armed robbery attempt
    In Justice News
    A 41-year-old Corpus [Read More…]
  • Justice Department Requires Divestitures in Lactalis’s Acquisition of Kraft Heinz’s Natural Cheese Business in the United States
    In Crime News
    The Department of Justice announced today that it will require B.S.A. S.A. (Lactalis) and The Kraft Heinz Company (Kraft Heinz) to divest Kraft Heinz’s Athenos and Polly-O businesses in order to proceed with Lactalis’s proposed acquisition of Kraft Heinz’s natural cheese business in the United States.
    [Read More…]
Network News © 2005 Area.Control.Network™ All rights reserved.